159 related articles for article (PubMed ID: 31157550)
21. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum.
Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G
Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415
[TBL] [Abstract][Full Text] [Related]
22. Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes.
Conti V; Corbi G; Polito MV; Ciccarelli M; Manzo V; Torsiello M; De Bellis E; D'Auria F; Vitulano G; Piscione F; Carrizzo A; Di Pietro P; Vecchione C; Ferrara N; Filippelli A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33238655
[TBL] [Abstract][Full Text] [Related]
23. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups.
Martinsson A; Oest P; Wiborg MB; Reitan Ö; Smith JG
Scand Cardiovasc J; 2018 Aug; 52(4):205-210. PubMed ID: 29656687
[TBL] [Abstract][Full Text] [Related]
25. Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.
Parikh RH; Seliger SL; Christenson R; Gottdiener JS; Psaty BM; deFilippi CR
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481133
[TBL] [Abstract][Full Text] [Related]
26. Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure.
Montoro-García S; Shantsila E; Wrigley BJ; Tapp LD; Abellán Alemán J; Lip GY
Rev Esp Cardiol (Engl Ed); 2015 Nov; 68(11):951-8. PubMed ID: 25819989
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
[TBL] [Abstract][Full Text] [Related]
28. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
[TBL] [Abstract][Full Text] [Related]
29. Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction.
Sugano A; Seo Y; Ishizu T; Sai S; Yamamoto M; Hamada-Harimura Y; Machino-Ohtsuka T; Obara K; Nishi I; Aonuma K; Nogami A
J Cardiol; 2019 Apr; 73(4):326-332. PubMed ID: 30580891
[TBL] [Abstract][Full Text] [Related]
30. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
Chen X; Savarese G; Dahlström U; Lund LH; Fu M
Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
[TBL] [Abstract][Full Text] [Related]
32. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
33. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
[TBL] [Abstract][Full Text] [Related]
34. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
35. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
36. Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction.
Beltrami M; Ruocco G; Dastidar AG; Franci B; Lucani B; Aloia E; Nuti R; Palazzuoli A
Clin Chim Acta; 2016 Jun; 457():99-105. PubMed ID: 27067445
[TBL] [Abstract][Full Text] [Related]
37. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
[TBL] [Abstract][Full Text] [Related]
38. Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology.
Zhang M; Meng Q; Qi X; Han Q; Qi X; Wang F; Du B
Biomark Med; 2018 Nov; 12(11):1207-1217. PubMed ID: 30499308
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction.
Friões F; Lourenço P; Laszczynska O; Almeida PB; Guimarães JT; Januzzi JL; Azevedo A; Bettencourt P
Clin Res Cardiol; 2015 Jun; 104(6):491-9. PubMed ID: 25586507
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]